Lack of competition of substrates for P-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1

Advances in Enzyme Regulation

Volumn 39, Issue 1, 1999, Pages 113-128

  Hall, Jennifer G ^a   Cory, Ann H ^a   Cory, Joseph G ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DACTINOMYCIN; DAUNORUBICIN; DEOXYGLUCOSE; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; NUCLEOTIDE; RHODAMINE 123; SODIUM AZIDE; VERAPAMIL; VINBLASTINE;

BREAST CANCER; BREAST TUMOR; CELL CULTURE; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RETENTION; DRUG UPTAKE; ENERGY METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETICS; GLYCOLYSIS; HUMAN; HUMAN CELL; METABOLISM; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION;

EID: 0032856396     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(98)00012-0     Document Type: Conference Paper

References (16)

1. A. S. LEVENSON and V. C. JORDAN, MCF-7: the first hormone-responsive breast cancer cell line, Cancer Res. 57, 3071-3078 (1997).
2. C. R. FAIRCHILD, S. P. IVY, C.-S. KAO-SHAN, J. WHANG-PENG, N. ROSEN, M. A. ISRAEL, P. W. MELERA, K. H. COWAN and M. E. GOLDSMITH, Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells, Cancer Res. 47, 5141-5148 (1987).
3. G. BATIST, A. TULPULE, B. K. SINHA, A. G. KATKI, C. E. MEYERS and K. H. COWAN, Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells, J. Biol. Chem. 261, 15544-15549 (1986).
4. S. SCALA, N. AKHMED, U. S. RAO, K. PAULL, L.-B. LAN, B. DICKSTEIN, J.-S. LEE, G. H. ELGEMLIE, W. D. STEIN and S. E. BATES, P-Glycoprotein substrates and antagonists cluster into two distinct groups, Mol. Pharmacol. 51, 1024-1033 (1997).
5. G. J. SCHUURHUIS, H. J. BROXTERMAN, A. CERVANTES, T. H. VAN HEIJNINGEN, J. H. DE LANGE, J. P. BAAK, H. M. PINEDO and J. LANKELMA, Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells, J. Natl. Cancer Inst. 81, 1887-1892 (1989).
6. A. H. CORY, A.-W. R. HE and J. G. CORY, Multifactorial mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents, Advan. Enzyme Regul. 38, 1-16 (1998).
7. A.-W. R. HE and J. G. CORY, p53-Independent WAF1 and GADD45 induction after DNA damage, Mol. Biol. Cell (supplement) 7, 22a (1996).
8. G. C. YEH, S. J. OCCHIPINTI, K. H. COWAN, B. A. CHABNER and C. E. MEYERS, Adriamycin resistance in human tumor cells associated with marked alterations in the regulation of the hexose monophosphate shunt and its response to oxidant stress, Cancer Res. 47, 5994-5999 (1987).
9. B. OGRETMAN and A. R. SAFA, Expression of mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/ Adr human breast cancer cells, Oncogene 14, 499-506 (1997).
10. Y. SHOJI, M. H. FISHER, A. PERIASAMY, B. HERMAN and R. L. JULIANO, Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanisms, Cancer Lett. 57, 208-218 (1991).
11. H. J. BROXTERMAN, H. M. PINEDO, C. M. KUIPER, L. C. KAPTEIN, G. J. SCHUURHUIS and J. LANKELMA, Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells, FASEB J. 2, 2278-2282 (1988).
12. H. J. BROXTERMAN, H. M. PINEDO, G. J. SCHUURHUIS and J. LANKELMA, Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells, Brit. J. Cancer 62, 85-88 (1990).
13. J. E. GERVASONI JR., S. Z. FIELDS, S. KRISHNA, M. A. BAKER, M. ROSADO, K. THURAISAMY, A. A. HINDENBURG and R. N. TAUB, Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy, Cancer Res. 51, 4955-4963 (1991).
14. J. L. WEBB, Enzyme and Metabolic Inhibitors, Vol 1. Academic Press, Inc., New York (1963).
15. E. C. SPOELSTRA, H. V. WESTERKOFF, H. M. PINEDO, H. DEKKER and J. LANKELMA, The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate, Eur. J. Biochem. 221, 363-373 (1994).
16. T. W. LOO and D. M. CLARKE, Mutations to amino acids located in predicted transmembrane segment (TM6) modulate the activity and substrate specificity of human P-glycoprotein, Biochemistry 33, 14049-14057 (1994).